Fujian Haixi Pharmaceuticals Co., Ltd. (Haixi Pharma) has scheduled a board meeting for Friday, 28 August 2026. The agenda includes:

• Reviewing and approving the Group’s interim financial results for the six months ended 30 June 2026. • Considering a potential interim dividend for shareholders. • Handling other routine corporate matters.

The meeting will be chaired by Executive Director, Chairman and General Manager Dr. Kang Xinshan. The current board comprises five executive directors, one non-executive director and three independent non-executive directors, underscoring a governance structure that balances management oversight with independent supervision.

The company plans to release its approved interim results to the market following the board’s deliberations.